Development and automation of an ultra-concentrated bioactive compound containing plasma and platelet proteins for the treatment of anterior segment eye pathologies (BEGIKOREKA)

Periodo de ejecución
2022 - 2024.
Áreas de la medicina
Ophthalmology
Áreas de investigación
Tissue regeneration
N de paginas
228
N de ilustraciones
350
Campo 6
Valor 6
Campo 7
Valor 7
Campo 8
Valor 8
Campo 9
Valor 9
Campo 10
Valor 10

The primary objective of this project is to develop an ultra-concentrated bioactive compound containing plasma and platelet proteins that increases the bioavailability of proteins and growth factors in the tissues comprising the trabecular meshwork, thereby promoting tissue regeneration.

* Project co-funded by the Basque Government and the European Union through the European Regional Development Fund 2021–2027 (ERDF)